NCT06907745

Brief Summary

Accuracy assessment through three-dimensional superposition of the post-operative volumetric CT and the digital therapeutic project files.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
28

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 24, 2024

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

May 18, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
6 months until next milestone

First Posted

Study publicly available on registry

April 2, 2025

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 2, 2025

Status Verified

June 1, 2024

Enrollment Period

5 months

First QC Date

May 18, 2024

Last Update Submit

March 26, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Accuracy evaluation

    3D superposition of post-operative volumetric CT and the digital therapeutic project files. The variables and parameters analysis will be performed after the data distribution analysis, using the D'Agostino Pearson omnibus normality test: normal distribution data will be expressed as mean and standard deviation; non-normal distribution data will be expressed as median and interquartile range. The quantitative and qualitative variables will be expressed in terms of absolute frequencies and percentage value. Image superposition accuracy will be defined by measuring distances between the different anatomical reference points, considering excellent accuracy for distances less than 2 mm. Correlation and multivariate analysis models will be developed to define the secondary outcomes.

    1 month post-op

Interventions

Maxillary LeFort I osteotomy and mandible osteotomy (BSSO) without intermediate splint.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with diagnosis of dentoskeletal disorders

You may qualify if:

  • Men and women
  • Age over 18 and under 60
  • Diagnosis of dento-skeletal dysmorphosis involving the middle third and lower part of the face
  • Patients with consent to surgery
  • Patients in good general health according to the evaluation of the PI and on the basis of the anamnesis and clinical examination

You may not qualify if:

  • History of previous maxillomandibular fracture
  • Treatment with anticoagulant drugs
  • Treatment with intravenous bisphosphonates
  • Treatment with anticonvulsants
  • Patient's inability to maintain home hygiene standards in accordance with the study requirements
  • History of drug and/or alcohol abuse
  • Chronic corticosteroid therapy
  • Radiotherapy, chemotherapy and/or immunosuppressive treatment or radiotherapy in the last 5 years
  • Psychosis
  • Pregnant or breastfeeding
  • Poor compliance
  • Endocrinological disorders in poor pharmacological control
  • Other uncontrolled systemic conditions that preclude performing surgical procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Ospedale Galeazzi-Sant'Ambrogio

Milan, Milan, 20157, Italy

RECRUITING

MeSH Terms

Conditions

Dentofacial Deformities

Condition Hierarchy (Ancestors)

Maxillofacial AbnormalitiesCraniofacial AbnormalitiesMusculoskeletal AbnormalitiesMusculoskeletal DiseasesStomatognathic System AbnormalitiesStomatognathic DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Alessandro Baj, Prof

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2024

First Posted

April 2, 2025

Study Start

April 24, 2024

Primary Completion

September 30, 2024

Study Completion

December 31, 2025

Last Updated

April 2, 2025

Record last verified: 2024-06

Locations